Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Adjuvant/Neoadjuvant

Hussein Tawbi

MD, PhD

🏢MD Anderson Cancer Center🌐USA

Professor, Department of Melanoma Medical Oncology

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Hussein Tawbi led the landmark CheckMate 204 trial demonstrating efficacy of nivolumab-ipilimumab for melanoma brain metastases, transforming management of this challenging clinical scenario. His expertise spans adjuvant, neoadjuvant, and advanced melanoma treatment approaches. He is a leading voice in optimizing immunotherapy combinations for high-risk melanoma.

Share:

🧪Research Fields 研究领域

Melanoma
Brain metastases
Combination immunotherapy
Adjuvant therapy
Translational immunology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Hussein Tawbi 的研究动态

Follow Hussein Tawbi's research updates

留下邮箱,当我们发布与 Hussein Tawbi(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment